Immutep Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.233x

Immutep Ltd cash flow conversion efficiency. Based on the latest financial reports, Immutep Ltd (IMM) has a cash flow conversion efficiency ratio of -0.233x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-33.50 Million ≈ $-23.71 Million USD) by net assets (AU$143.64 Million ≈ $101.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Immutep Ltd (2004–2025)

Cash flow conversion efficiency of Immutep Ltd from 2004 to 2025. This chart illustrates how Immutep Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Immutep Ltd for real-time trading data and today's change.

Immutep Ltd Cash Flow Conversion Ratio Explained

Immutep Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Immutep Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immutep Ltd ranked by their cash flow conversion efficiency. Also see IMM company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Maniker F & G Co. Ltd
KQ:195500
0.043x
Daebo Magnetic Co.Ltd
KQ:290670
-0.063x
Formetal Co. Ltd
KQ:119500
-0.013x
OPCOM Holdings Bhd
KLSE:0035
-0.001x
Aciselsan Acipayam Seluloz Sanayi Ve Ticaret AS
IS:ACSEL
0.026x
Kidoz Inc
V:KIDZ
0.061x
SP Systems Co.Ltd
KQ:317830
0.010x
Protasco Bhd
KLSE:5070
0.007x

Annual Cash Flow Conversion Efficiency for Immutep Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Immutep Ltd from 2004 to 2025. Review Immutep Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$143.64 Million
≈ $101.63 Million
AU$-62.05 Million
≈ $-43.90 Million
-0.432x -135.12%
2024-06-30 AU$189.52 Million
≈ $134.10 Million
AU$-34.82 Million
≈ $-24.64 Million
-0.184x +30.12%
2023-06-30 AU$136.47 Million
≈ $96.56 Million
AU$-35.88 Million
≈ $-25.39 Million
-0.263x +18.17%
2022-06-30 AU$94.08 Million
≈ $66.57 Million
AU$-30.23 Million
≈ $-21.39 Million
-0.321x -33.47%
2021-06-30 AU$73.27 Million
≈ $51.84 Million
AU$-17.64 Million
≈ $-12.48 Million
-0.241x +26.04%
2020-06-30 AU$33.30 Million
≈ $23.56 Million
AU$-10.84 Million
≈ $-7.67 Million
-0.326x +48.07%
2019-06-30 AU$24.39 Million
≈ $17.26 Million
AU$-15.29 Million
≈ $-10.82 Million
-0.627x -176573.57%
2018-06-30 AU$33.52 Million
≈ $23.72 Million
AU$-11.89K
≈ $-8.42K
0.000x +99.89%
2017-06-30 AU$26.53 Million
≈ $18.77 Million
AU$-8.51 Million
≈ $-6.02 Million
-0.321x -0.12%
2016-06-30 AU$35.32 Million
≈ $24.99 Million
AU$-11.31 Million
≈ $-8.00 Million
-0.320x -1.53%
2015-06-30 AU$24.69 Million
≈ $17.47 Million
AU$-7.79 Million
≈ $-5.51 Million
-0.315x +49.92%
2014-06-30 AU$22.59 Million
≈ $15.99 Million
AU$-14.23 Million
≈ $-10.07 Million
-0.630x -14.85%
2013-06-30 AU$29.25 Million
≈ $20.70 Million
AU$-16.04 Million
≈ $-11.35 Million
-0.548x -6.56%
2012-06-30 AU$37.16 Million
≈ $26.29 Million
AU$-19.12 Million
≈ $-13.53 Million
-0.515x -190.62%
2011-06-30 AU$55.10 Million
≈ $38.99 Million
AU$-9.76 Million
≈ $-6.90 Million
-0.177x +54.00%
2010-06-30 AU$16.79 Million
≈ $11.88 Million
AU$-6.46 Million
≈ $-4.57 Million
-0.385x +62.96%
2009-06-30 AU$1.81 Million
≈ $1.28 Million
AU$-1.88 Million
≈ $-1.33 Million
-1.039x -76.06%
2008-06-30 AU$2.63 Million
≈ $1.86 Million
AU$-1.55 Million
≈ $-1.10 Million
-0.590x +27.67%
2007-06-30 AU$4.08 Million
≈ $2.89 Million
AU$-3.33 Million
≈ $-2.36 Million
-0.816x -2.03%
2006-06-30 AU$6.32 Million
≈ $4.47 Million
AU$-5.05 Million
≈ $-3.57 Million
-0.800x -40.92%
2005-06-30 AU$8.34 Million
≈ $5.90 Million
AU$-4.73 Million
≈ $-3.35 Million
-0.568x +48.43%
2004-06-30 AU$5.13 Million
≈ $3.63 Million
AU$-5.64 Million
≈ $-3.99 Million
-1.100x --

About Immutep Ltd

AU:IMM Australia Biotechnology
Market Cap
$21.87 Million
AU$30.91 Million AUD
Market Cap Rank
#24646 Global
#997 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.46
All Time High
AU$0.68
About

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes… Read more